Results 221 to 230 of about 315,177 (310)

A different alternative to warfarin? [PDF]

Blood Adv
Morrissey JH.
europepmc   +1 more source

Bridging Anticoagulation

Journal of the American College of Cardiology, 2016
Schwartz, Marc L., Breecker, Steven W.
openaire   +2 more sources

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Pharmacological Management of Thrombosis: Current State and Future Strategies. [PDF]

Int J Mol Sci
Mogielnicki A.
europepmc   +1 more source

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher, Felix Lindberg, Lina Benson, Camilla Hage, Ulf Dahlström, Stephan Rosenkranz, Francesco Cosentino, Giuseppe M.C. Rosano, Stefan Blankenberg, Paulus Kirchhof, Frieder Braunschweig, Lars H. Lund, Gianluigi Savarese   +12 more
wiley   +1 more source

Impact of Combined Anticoagulant and Antiplatelet Therapy in Older Patients With Atrial Fibrillation: ANAFIE Subanalysis. [PDF]

J Am Heart Assoc
Kamogawa N, Toyoda K, Yamaguchi T, Inoue H, Yamashita T, Suzuki S, Kobayashi H, Miwa K, Yoshimura S, Inoue M, Ihara M, Ago T, Koga M, ANAFIE investigators.   +13 more
europepmc   +1 more source

A Case of Childhood Lupus Anticoagulant-Hypoprothrombinemia Syndrome with Diagnostic and Therapeutic Insight. [PDF]

Pediatric Health Med Ther
Zhou B, Jiao W, Li Y, Hou Y, Zhu F, Yang X.   +5 more
europepmc   +1 more source

Epidemiology of hospitalized heart failure in France based on national data over 10 years, 2012–2022

ESC Heart Failure, Volume 12, Issue 2, Page 1283-1294, April 2025.
Abstract Aims We aim to describe the incidence of HF hospitalization in France in the post‐pandemic era, the prevalence of HF cases and patients' characteristics, management and outcomes while focusing on sex, age and socio‐economic differences and to analyse time‐trends between 2012 and 2022.
Valérie Olié, Richard Isnard, Françoise Pousset, Clémence Grave, Jacques Blacher, Amélie Gabet   +5 more
wiley   +1 more source

Prevalence and Clinical Characteristics of Isolated Intraventricular Hemorrhage. [PDF]

Cerebrovasc Dis Extra
Arakaki Y, Miwa K, Shiozawa M, Ogawa A, Inutsuka R, Usui R, Iwamoto S, Nakahara J, Toyoda K, Ihara M, Koga M.   +10 more
europepmc   +1 more source

Why Pediatric CAR‐T Therapies Still Lag Behind: Insights from Six Treatments Centrally Approved in Europe

Clinical Pharmacology &Therapeutics, EarlyView.
Lisa Hanquet, Jean‐Michel Dogné, Flora T. Musuamba   +2 more
wiley   +1 more source